This was given to me from someone on a different board. Most of you don't want to click on the link below because it brings you to a blog on Bruce Patterson and his longhaulers work(and a pitch for donations). So, I will give you the part worth reading.

Treatment

CCR5 Antagonists to the Fore?

Calling them “an exciting new class of drugs that modulate the immune system”, Patterson believes that CCR5 antagonists like maraviroc, leronlimab, and statins like pravastatin are going to play a major role in treating these diseases.

CCR5 is a “chemokine”- a kind of cytokine that shepherds’ immune cells toward a site of infection. CCR5 antagonists were developed in response to HIV when it was discovered that some people who were immune to the virus had a mutation that codes differently for the CCR5 receptor. Maraviroc and leronlimab are two CCR5 antagonists mentioned by Patterson, and others exist. They block the monocytes from binding to and inflaming the endothelial cells on the blood cells, thereby decreasing VEGF, TNF-a, and IL-6. Patterson stated that approach has been “very, very effective.”

https://www.healthrising.org/blog/2021/12/12/...romyalgia/